nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—CACNB3—bronchus—esophageal cancer	0.0132	0.0673	CbGeAlD
Nimodipine—Phlebitis—Carboplatin—esophageal cancer	0.0121	0.066	CcSEcCtD
Nimodipine—CACNB3—trachea—esophageal cancer	0.0118	0.0604	CbGeAlD
Nimodipine—CACNB4—lung—esophageal cancer	0.0111	0.0567	CbGeAlD
Nimodipine—CACNB3—digestive system—esophageal cancer	0.0102	0.052	CbGeAlD
Nimodipine—AHR—bronchus—esophageal cancer	0.00977	0.0498	CbGeAlD
Nimodipine—AHR—smooth muscle tissue—esophageal cancer	0.00956	0.0488	CbGeAlD
Nimodipine—Vasospasm—Capecitabine—esophageal cancer	0.0091	0.0496	CcSEcCtD
Nimodipine—AHR—trachea—esophageal cancer	0.00877	0.0448	CbGeAlD
Nimodipine—CACNB3—lung—esophageal cancer	0.00851	0.0434	CbGeAlD
Nimodipine—AHR—digestive system—esophageal cancer	0.00755	0.0385	CbGeAlD
Nimodipine—CACNA1C—smooth muscle tissue—esophageal cancer	0.00699	0.0357	CbGeAlD
Nimodipine—CACNB2—digestive system—esophageal cancer	0.00684	0.0349	CbGeAlD
Nimodipine—NR3C2—bronchus—esophageal cancer	0.00651	0.0332	CbGeAlD
Nimodipine—NR3C2—smooth muscle tissue—esophageal cancer	0.00637	0.0325	CbGeAlD
Nimodipine—AHR—lung—esophageal cancer	0.0063	0.0322	CbGeAlD
Nimodipine—CACNB1—lymph node—esophageal cancer	0.00607	0.031	CbGeAlD
Nimodipine—NR3C2—trachea—esophageal cancer	0.00584	0.0298	CbGeAlD
Nimodipine—CACNB3—lymph node—esophageal cancer	0.00582	0.0297	CbGeAlD
Nimodipine—CACNB2—lung—esophageal cancer	0.00572	0.0292	CbGeAlD
Nimodipine—CACNA1C—digestive system—esophageal cancer	0.00552	0.0282	CbGeAlD
Nimodipine—Platelet count decreased—Capecitabine—esophageal cancer	0.00523	0.0285	CcSEcCtD
Nimodipine—Amlodipine—CA1—esophageal cancer	0.00518	0.228	CrCbGaD
Nimodipine—Deep vein thrombosis—Capecitabine—esophageal cancer	0.00511	0.0279	CcSEcCtD
Nimodipine—NR3C2—digestive system—esophageal cancer	0.00503	0.0256	CbGeAlD
Nimodipine—CACNA1D—lung—esophageal cancer	0.005	0.0255	CbGeAlD
Nimodipine—Haematoma—Capecitabine—esophageal cancer	0.00495	0.027	CcSEcCtD
Nimodipine—CACNA1C—lung—esophageal cancer	0.00461	0.0235	CbGeAlD
Nimodipine—Ileus—Capecitabine—esophageal cancer	0.00439	0.0239	CcSEcCtD
Nimodipine—AHR—lymph node—esophageal cancer	0.00431	0.022	CbGeAlD
Nimodipine—NR3C2—lung—esophageal cancer	0.0042	0.0214	CbGeAlD
Nimodipine—Wheezing—Cisplatin—esophageal cancer	0.0041	0.0223	CcSEcCtD
Nimodipine—Fluid retention—Cisplatin—esophageal cancer	0.004	0.0218	CcSEcCtD
Nimodipine—CACNB2—lymph node—esophageal cancer	0.00391	0.0199	CbGeAlD
Nimodipine—Deep vein thrombosis—Methotrexate—esophageal cancer	0.0038	0.0207	CcSEcCtD
Nimodipine—Phlebitis—Cisplatin—esophageal cancer	0.00355	0.0194	CcSEcCtD
Nimodipine—CACNA1D—lymph node—esophageal cancer	0.00342	0.0174	CbGeAlD
Nimodipine—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00338	0.0184	CcSEcCtD
Nimodipine—Nilvadipine—CYP2A6—esophageal cancer	0.00327	0.144	CrCbGaD
Nimodipine—CACNA1C—lymph node—esophageal cancer	0.00315	0.0161	CbGeAlD
Nimodipine—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.00311	0.0169	CcSEcCtD
Nimodipine—Hyponatraemia—Cisplatin—esophageal cancer	0.00307	0.0168	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.00306	0.0167	CcSEcCtD
Nimodipine—Fluid retention—Capecitabine—esophageal cancer	0.00295	0.0161	CcSEcCtD
Nimodipine—NR3C2—lymph node—esophageal cancer	0.00287	0.0147	CbGeAlD
Nimodipine—Amlodipine—CYP2A6—esophageal cancer	0.00281	0.124	CrCbGaD
Nimodipine—Cramp muscle—Cisplatin—esophageal cancer	0.00276	0.015	CcSEcCtD
Nimodipine—CYP3A5—digestive system—esophageal cancer	0.00272	0.0139	CbGeAlD
Nimodipine—Phlebitis—Capecitabine—esophageal cancer	0.00262	0.0143	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.00259	0.0141	CcSEcCtD
Nimodipine—Sweating increased—Cisplatin—esophageal cancer	0.00258	0.0141	CcSEcCtD
Nimodipine—Nifedipine—ABCC2—esophageal cancer	0.00254	0.112	CrCbGaD
Nimodipine—Nifedipine—CYP2A6—esophageal cancer	0.00252	0.111	CrCbGaD
Nimodipine—CYP3A5—lung—esophageal cancer	0.00227	0.0116	CbGeAlD
Nimodipine—Hyponatraemia—Capecitabine—esophageal cancer	0.00227	0.0124	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.00226	0.0123	CcSEcCtD
Nimodipine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00223	0.0122	CcSEcCtD
Nimodipine—Bradycardia—Cisplatin—esophageal cancer	0.00216	0.0118	CcSEcCtD
Nimodipine—Liver function test abnormal—Capecitabine—esophageal cancer	0.00208	0.0114	CcSEcCtD
Nimodipine—CYP3A4—digestive system—esophageal cancer	0.00204	0.0104	CbGeAlD
Nimodipine—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00199	0.0109	CcSEcCtD
Nimodipine—Flushing—Cisplatin—esophageal cancer	0.00197	0.0107	CcSEcCtD
Nimodipine—Cardiac disorder—Cisplatin—esophageal cancer	0.00197	0.0107	CcSEcCtD
Nimodipine—Immune system disorder—Cisplatin—esophageal cancer	0.00191	0.0104	CcSEcCtD
Nimodipine—Sweating increased—Capecitabine—esophageal cancer	0.0019	0.0104	CcSEcCtD
Nimodipine—Muscle spasms—Cisplatin—esophageal cancer	0.00177	0.00966	CcSEcCtD
Nimodipine—Depression—Capecitabine—esophageal cancer	0.00173	0.00945	CcSEcCtD
Nimodipine—Anaemia—Cisplatin—esophageal cancer	0.0017	0.00929	CcSEcCtD
Nimodipine—Jaundice—Capecitabine—esophageal cancer	0.0017	0.00924	CcSEcCtD
Nimodipine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00164	0.00897	CcSEcCtD
Nimodipine—Bradycardia—Capecitabine—esophageal cancer	0.00159	0.00866	CcSEcCtD
Nimodipine—Myalgia—Cisplatin—esophageal cancer	0.00157	0.00856	CcSEcCtD
Nimodipine—Hepatitis—Capecitabine—esophageal cancer	0.00156	0.00851	CcSEcCtD
Nimodipine—Liver function test abnormal—Methotrexate—esophageal cancer	0.00155	0.00846	CcSEcCtD
Nimodipine—Oedema—Cisplatin—esophageal cancer	0.0015	0.0082	CcSEcCtD
Nimodipine—Nervous system disorder—Cisplatin—esophageal cancer	0.00148	0.00804	CcSEcCtD
Nimodipine—Thrombocytopenia—Cisplatin—esophageal cancer	0.00147	0.00803	CcSEcCtD
Nimodipine—Tachycardia—Cisplatin—esophageal cancer	0.00147	0.00801	CcSEcCtD
Nimodipine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00145	0.00793	CcSEcCtD
Nimodipine—Cardiac disorder—Capecitabine—esophageal cancer	0.00145	0.0079	CcSEcCtD
Nimodipine—Flushing—Capecitabine—esophageal cancer	0.00145	0.0079	CcSEcCtD
Nimodipine—Angiopathy—Capecitabine—esophageal cancer	0.00142	0.00772	CcSEcCtD
Nimodipine—Immune system disorder—Capecitabine—esophageal cancer	0.00141	0.00769	CcSEcCtD
Nimodipine—Hypotension—Cisplatin—esophageal cancer	0.00141	0.00767	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00137	0.00747	CcSEcCtD
Nimodipine—Dyspnoea—Cisplatin—esophageal cancer	0.00134	0.00731	CcSEcCtD
Nimodipine—Muscle spasms—Capecitabine—esophageal cancer	0.00131	0.00712	CcSEcCtD
Nimodipine—Nisoldipine—ABCB1—esophageal cancer	0.0013	0.0573	CrCbGaD
Nimodipine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.0013	0.00708	CcSEcCtD
Nimodipine—Depression—Methotrexate—esophageal cancer	0.00129	0.00704	CcSEcCtD
Nimodipine—Anaemia—Capecitabine—esophageal cancer	0.00126	0.00685	CcSEcCtD
Nimodipine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00122	0.00668	CcSEcCtD
Nimodipine—Nitrendipine—ABCB1—esophageal cancer	0.00122	0.0536	CrCbGaD
Nimodipine—Palpitations—Capecitabine—esophageal cancer	0.0012	0.00655	CcSEcCtD
Nimodipine—Hypertension—Capecitabine—esophageal cancer	0.00117	0.0064	CcSEcCtD
Nimodipine—Hepatitis—Methotrexate—esophageal cancer	0.00116	0.00634	CcSEcCtD
Nimodipine—Myalgia—Capecitabine—esophageal cancer	0.00116	0.00631	CcSEcCtD
Nimodipine—Oedema—Capecitabine—esophageal cancer	0.00111	0.00605	CcSEcCtD
Nimodipine—Hypersensitivity—Cisplatin—esophageal cancer	0.00111	0.00604	CcSEcCtD
Nimodipine—Nervous system disorder—Capecitabine—esophageal cancer	0.00109	0.00593	CcSEcCtD
Nimodipine—Thrombocytopenia—Capecitabine—esophageal cancer	0.00109	0.00592	CcSEcCtD
Nimodipine—Tachycardia—Capecitabine—esophageal cancer	0.00108	0.0059	CcSEcCtD
Nimodipine—Cardiac disorder—Methotrexate—esophageal cancer	0.00108	0.00588	CcSEcCtD
Nimodipine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00107	0.00585	CcSEcCtD
Nimodipine—Angiopathy—Methotrexate—esophageal cancer	0.00105	0.00575	CcSEcCtD
Nimodipine—Immune system disorder—Methotrexate—esophageal cancer	0.00105	0.00572	CcSEcCtD
Nimodipine—Amlodipine—ABCB1—esophageal cancer	0.00105	0.0461	CrCbGaD
Nimodipine—Hypotension—Capecitabine—esophageal cancer	0.00104	0.00565	CcSEcCtD
Nimodipine—Diarrhoea—Cisplatin—esophageal cancer	0.00103	0.00561	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00101	0.00551	CcSEcCtD
Nimodipine—Dyspnoea—Capecitabine—esophageal cancer	0.000989	0.00539	CcSEcCtD
Nimodipine—Felodipine—ABCB1—esophageal cancer	0.000968	0.0426	CrCbGaD
Nimodipine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000958	0.00522	CcSEcCtD
Nimodipine—Vomiting—Cisplatin—esophageal cancer	0.000957	0.00522	CcSEcCtD
Nimodipine—Rash—Cisplatin—esophageal cancer	0.000949	0.00517	CcSEcCtD
Nimodipine—Dermatitis—Cisplatin—esophageal cancer	0.000948	0.00517	CcSEcCtD
Nimodipine—Nifedipine—ABCB1—esophageal cancer	0.000936	0.0412	CrCbGaD
Nimodipine—Anaemia—Methotrexate—esophageal cancer	0.000935	0.0051	CcSEcCtD
Nimodipine—Nicardipine—ABCB1—esophageal cancer	0.000922	0.0406	CrCbGaD
Nimodipine—Nausea—Cisplatin—esophageal cancer	0.000894	0.00487	CcSEcCtD
Nimodipine—Myalgia—Methotrexate—esophageal cancer	0.000861	0.0047	CcSEcCtD
Nimodipine—Hypersensitivity—Capecitabine—esophageal cancer	0.000817	0.00446	CcSEcCtD
Nimodipine—Nervous system disorder—Methotrexate—esophageal cancer	0.00081	0.00441	CcSEcCtD
Nimodipine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000809	0.00441	CcSEcCtD
Nimodipine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000798	0.00435	CcSEcCtD
Nimodipine—Pruritus—Capecitabine—esophageal cancer	0.000785	0.00428	CcSEcCtD
Nimodipine—Hypotension—Methotrexate—esophageal cancer	0.000772	0.00421	CcSEcCtD
Nimodipine—Diarrhoea—Capecitabine—esophageal cancer	0.000759	0.00414	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000752	0.0041	CcSEcCtD
Nimodipine—Dyspnoea—Methotrexate—esophageal cancer	0.000736	0.00401	CcSEcCtD
Nimodipine—Dizziness—Capecitabine—esophageal cancer	0.000734	0.004	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000713	0.00389	CcSEcCtD
Nimodipine—Vomiting—Capecitabine—esophageal cancer	0.000705	0.00384	CcSEcCtD
Nimodipine—Rash—Capecitabine—esophageal cancer	0.000699	0.00381	CcSEcCtD
Nimodipine—Dermatitis—Capecitabine—esophageal cancer	0.000699	0.00381	CcSEcCtD
Nimodipine—Headache—Capecitabine—esophageal cancer	0.000695	0.00379	CcSEcCtD
Nimodipine—Nausea—Capecitabine—esophageal cancer	0.000659	0.00359	CcSEcCtD
Nimodipine—Hypersensitivity—Methotrexate—esophageal cancer	0.000608	0.00332	CcSEcCtD
Nimodipine—Pruritus—Methotrexate—esophageal cancer	0.000584	0.00318	CcSEcCtD
Nimodipine—Diarrhoea—Methotrexate—esophageal cancer	0.000565	0.00308	CcSEcCtD
Nimodipine—Dizziness—Methotrexate—esophageal cancer	0.000546	0.00298	CcSEcCtD
Nimodipine—Vomiting—Methotrexate—esophageal cancer	0.000525	0.00286	CcSEcCtD
Nimodipine—Rash—Methotrexate—esophageal cancer	0.000521	0.00284	CcSEcCtD
Nimodipine—Dermatitis—Methotrexate—esophageal cancer	0.00052	0.00284	CcSEcCtD
Nimodipine—Headache—Methotrexate—esophageal cancer	0.000517	0.00282	CcSEcCtD
Nimodipine—Nausea—Methotrexate—esophageal cancer	0.00049	0.00267	CcSEcCtD
Nimodipine—CACNA1D—Axon guidance—KDR—esophageal cancer	0.000364	0.000609	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000362	0.000606	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—ABL1—esophageal cancer	0.000362	0.000605	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PLCE1—esophageal cancer	0.000362	0.000605	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ADH7—esophageal cancer	0.000362	0.000605	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—CYP1B1—esophageal cancer	0.00036	0.000602	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MET—esophageal cancer	0.000356	0.000596	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CA1—esophageal cancer	0.000354	0.000592	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—SLC10A2—esophageal cancer	0.000354	0.000592	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—SMAD4—esophageal cancer	0.000351	0.000586	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—NOTCH3—esophageal cancer	0.00035	0.000585	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GSTT1—esophageal cancer	0.000348	0.000582	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP2A6—esophageal cancer	0.000344	0.000575	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—CYP19A1—esophageal cancer	0.000343	0.000574	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—ABL1—esophageal cancer	0.000343	0.000573	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ADH7—esophageal cancer	0.000342	0.000573	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PLCE1—esophageal cancer	0.000342	0.000573	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000338	0.000566	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—SMAD4—esophageal cancer	0.000332	0.000555	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—EP300—esophageal cancer	0.000327	0.000547	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ENO1—esophageal cancer	0.000326	0.000545	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTGS1—esophageal cancer	0.000326	0.000545	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CA2—esophageal cancer	0.000324	0.000541	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PSME2—esophageal cancer	0.000321	0.000537	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PSME1—esophageal cancer	0.000321	0.000537	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—ERBB2—esophageal cancer	0.000321	0.000537	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—ERBB2—esophageal cancer	0.000321	0.000536	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—KDR—esophageal cancer	0.00032	0.000535	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—KDR—esophageal cancer	0.00032	0.000535	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000319	0.000534	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000318	0.000531	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ADH1B—esophageal cancer	0.000317	0.00053	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—NOTCH2—esophageal cancer	0.000314	0.000525	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MET—esophageal cancer	0.000313	0.000524	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MET—esophageal cancer	0.000313	0.000524	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—ERBB2—esophageal cancer	0.000312	0.000523	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—EGFR—esophageal cancer	0.000312	0.000522	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—EGFR—esophageal cancer	0.000304	0.000508	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—TYMP—esophageal cancer	0.000303	0.000507	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—NOTCH1—esophageal cancer	0.000301	0.000504	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—ABL1—esophageal cancer	0.000301	0.000504	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PLCE1—esophageal cancer	0.000301	0.000503	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ADH7—esophageal cancer	0.000301	0.000503	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ADH1B—esophageal cancer	0.0003	0.000502	CbGpPWpGaD
Nimodipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.0003	0.000502	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000295	0.000494	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP26A1—esophageal cancer	0.000295	0.000493	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—SMAD4—esophageal cancer	0.000292	0.000488	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000291	0.000487	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ALOX15—esophageal cancer	0.000287	0.000481	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—TYMP—esophageal cancer	0.000287	0.00048	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP26A1—esophageal cancer	0.000279	0.000467	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—EGFR—esophageal cancer	0.000279	0.000466	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP1B1—esophageal cancer	0.000277	0.000464	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—ERBB2—esophageal cancer	0.000275	0.00046	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000274	0.000459	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—KDR—esophageal cancer	0.000274	0.000459	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—TPI1—esophageal cancer	0.000274	0.000458	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTO1—esophageal cancer	0.000274	0.000458	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—CREBBP—esophageal cancer	0.000273	0.000457	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ALOX15—esophageal cancer	0.000272	0.000455	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000271	0.000453	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MET—esophageal cancer	0.000268	0.000449	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ADH1B—esophageal cancer	0.000264	0.000441	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—SMAD4—esophageal cancer	0.000264	0.000441	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ALDOB—esophageal cancer	0.000263	0.00044	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—EP300—esophageal cancer	0.000261	0.000437	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CYP19A1—esophageal cancer	0.000261	0.000436	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—ERBB2—esophageal cancer	0.00026	0.000436	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—KDR—esophageal cancer	0.00026	0.000435	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTO1—esophageal cancer	0.00026	0.000434	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—TPI1—esophageal cancer	0.00026	0.000434	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—NOTCH1—esophageal cancer	0.000258	0.000432	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MET—esophageal cancer	0.000254	0.000425	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—EP300—esophageal cancer	0.000254	0.000425	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GAPDH—esophageal cancer	0.000253	0.000423	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TYMP—esophageal cancer	0.000252	0.000422	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CRABP1—esophageal cancer	0.000251	0.000419	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ALDOB—esophageal cancer	0.000249	0.000416	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP26A1—esophageal cancer	0.000245	0.00041	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—NOTCH1—esophageal cancer	0.000245	0.000409	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GAPDH—esophageal cancer	0.00024	0.000401	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ALOX15—esophageal cancer	0.000239	0.0004	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GNG7—esophageal cancer	0.000238	0.000399	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—HMOX1—esophageal cancer	0.000238	0.000398	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CRABP1—esophageal cancer	0.000237	0.000397	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—CREBBP—esophageal cancer	0.000234	0.000392	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—ERBB2—esophageal cancer	0.000229	0.000383	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—ERBB2—esophageal cancer	0.000229	0.000383	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KDR—esophageal cancer	0.000228	0.000382	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ABCB1—esophageal cancer	0.000228	0.000382	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TPI1—esophageal cancer	0.000228	0.000381	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTO1—esophageal cancer	0.000228	0.000381	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GNG7—esophageal cancer	0.000226	0.000378	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000224	0.000374	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ALDH2—esophageal cancer	0.000223	0.000374	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MET—esophageal cancer	0.000223	0.000374	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—EGFR—esophageal cancer	0.000223	0.000372	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—EGFR—esophageal cancer	0.000222	0.000372	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—CREBBP—esophageal cancer	0.000222	0.000371	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ALDOB—esophageal cancer	0.000219	0.000366	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—MYC—esophageal cancer	0.000217	0.000363	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—EGFR—esophageal cancer	0.000217	0.000362	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—NOTCH1—esophageal cancer	0.000215	0.00036	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000213	0.000356	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTT1—esophageal cancer	0.000213	0.000355	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ALDH2—esophageal cancer	0.000212	0.000354	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GAPDH—esophageal cancer	0.00021	0.000352	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.00021	0.000352	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP2A6—esophageal cancer	0.00021	0.000351	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CRABP1—esophageal cancer	0.000209	0.000349	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTT1—esophageal cancer	0.000201	0.000337	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000199	0.000334	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ENO1—esophageal cancer	0.000199	0.000333	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTGS1—esophageal cancer	0.000199	0.000333	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP2A6—esophageal cancer	0.000199	0.000333	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GNG7—esophageal cancer	0.000198	0.000332	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PSME1—esophageal cancer	0.000196	0.000328	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PSME2—esophageal cancer	0.000196	0.000328	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—ERBB2—esophageal cancer	0.000196	0.000328	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—CREBBP—esophageal cancer	0.000195	0.000326	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—NOTCH1—esophageal cancer	0.000194	0.000325	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—EGFR—esophageal cancer	0.000191	0.000319	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ENO1—esophageal cancer	0.000189	0.000315	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTGS1—esophageal cancer	0.000189	0.000315	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—EP300—esophageal cancer	0.000186	0.000311	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ALDH2—esophageal cancer	0.000186	0.000311	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PSME1—esophageal cancer	0.000186	0.000311	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PSME2—esophageal cancer	0.000186	0.000311	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—ERBB2—esophageal cancer	0.000186	0.000311	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC52A3—esophageal cancer	0.000184	0.000308	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—BLVRB—esophageal cancer	0.000184	0.000308	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—EGFR—esophageal cancer	0.000181	0.000302	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTT1—esophageal cancer	0.000177	0.000296	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—CREBBP—esophageal cancer	0.000176	0.000295	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP2A6—esophageal cancer	0.000175	0.000292	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.00017	0.000284	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP1B1—esophageal cancer	0.000169	0.000283	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000167	0.00028	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTGS1—esophageal cancer	0.000166	0.000277	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ENO1—esophageal cancer	0.000166	0.000277	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PSME2—esophageal cancer	0.000163	0.000273	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PSME1—esophageal cancer	0.000163	0.000273	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—ERBB2—esophageal cancer	0.000163	0.000273	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP1B1—esophageal cancer	0.00016	0.000268	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—EP300—esophageal cancer	0.00016	0.000267	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000159	0.000267	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CYP19A1—esophageal cancer	0.000159	0.000266	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—EGFR—esophageal cancer	0.000159	0.000265	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—EGFR—esophageal cancer	0.000159	0.000265	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000157	0.000263	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CA1—esophageal cancer	0.000157	0.000262	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC10A2—esophageal cancer	0.000157	0.000262	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CREBBP—esophageal cancer	0.000153	0.000255	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EP300—esophageal cancer	0.000151	0.000253	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CYP19A1—esophageal cancer	0.000151	0.000252	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—HMOX1—esophageal cancer	0.000145	0.000243	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CA2—esophageal cancer	0.000143	0.00024	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP1B1—esophageal cancer	0.000141	0.000236	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ABCB1—esophageal cancer	0.000139	0.000233	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—HMOX1—esophageal cancer	0.000138	0.00023	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—NOS3—esophageal cancer	0.000137	0.000228	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—EGFR—esophageal cancer	0.000136	0.000228	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ADH7—esophageal cancer	0.000133	0.000223	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PLCE1—esophageal cancer	0.000133	0.000223	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EP300—esophageal cancer	0.000133	0.000222	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CYP19A1—esophageal cancer	0.000132	0.000222	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ABCB1—esophageal cancer	0.000132	0.000221	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EGFR—esophageal cancer	0.000129	0.000215	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTGS2—esophageal cancer	0.000125	0.000209	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—HMOX1—esophageal cancer	0.000121	0.000202	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ADH1B—esophageal cancer	0.000117	0.000195	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ABCB1—esophageal cancer	0.000116	0.000194	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EGFR—esophageal cancer	0.000113	0.000189	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TYMP—esophageal cancer	0.000112	0.000187	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP26A1—esophageal cancer	0.000109	0.000182	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALOX15—esophageal cancer	0.000106	0.000177	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MYC—esophageal cancer	0.000105	0.000175	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—EP300—esophageal cancer	0.000104	0.000174	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTO1—esophageal cancer	0.000101	0.000169	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TPI1—esophageal cancer	0.000101	0.000169	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALDOB—esophageal cancer	9.68e-05	0.000162	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CREBBP—esophageal cancer	9.32e-05	0.000156	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GAPDH—esophageal cancer	9.32e-05	0.000156	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CRABP1—esophageal cancer	9.23e-05	0.000154	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CREBBP—esophageal cancer	8.83e-05	0.000148	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GNG7—esophageal cancer	8.78e-05	0.000147	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	8.57e-05	0.000143	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—BLVRB—esophageal cancer	8.57e-05	0.000143	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—NOS3—esophageal cancer	8.34e-05	0.00014	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ALDH2—esophageal cancer	8.23e-05	0.000138	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NOS3—esophageal cancer	7.9e-05	0.000132	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTT1—esophageal cancer	7.83e-05	0.000131	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CREBBP—esophageal cancer	7.75e-05	0.00013	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP2A6—esophageal cancer	7.74e-05	0.000129	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PIK3CA—esophageal cancer	7.69e-05	0.000129	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTGS2—esophageal cancer	7.63e-05	0.000128	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS1—esophageal cancer	7.33e-05	0.000123	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ENO1—esophageal cancer	7.33e-05	0.000123	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CA1—esophageal cancer	7.28e-05	0.000122	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	7.28e-05	0.000122	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PSME1—esophageal cancer	7.23e-05	0.000121	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PSME2—esophageal cancer	7.23e-05	0.000121	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTGS2—esophageal cancer	7.23e-05	0.000121	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NOS3—esophageal cancer	6.94e-05	0.000116	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CA2—esophageal cancer	6.66e-05	0.000111	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTGS2—esophageal cancer	6.35e-05	0.000106	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—EP300—esophageal cancer	6.35e-05	0.000106	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP1B1—esophageal cancer	6.24e-05	0.000104	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ADH7—esophageal cancer	6.19e-05	0.000104	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PLCE1—esophageal cancer	6.19e-05	0.000104	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—EP300—esophageal cancer	6.01e-05	0.000101	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP19A1—esophageal cancer	5.86e-05	9.81e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ADH1B—esophageal cancer	5.43e-05	9.08e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HMOX1—esophageal cancer	5.35e-05	8.95e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—EP300—esophageal cancer	5.28e-05	8.83e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TYMP—esophageal cancer	5.19e-05	8.68e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ABCB1—esophageal cancer	5.14e-05	8.59e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	5.05e-05	8.44e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALOX15—esophageal cancer	4.92e-05	8.23e-05	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PIK3CA—esophageal cancer	4.7e-05	7.85e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTO1—esophageal cancer	4.69e-05	7.85e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TPI1—esophageal cancer	4.69e-05	7.85e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALDOB—esophageal cancer	4.5e-05	7.53e-05	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PIK3CA—esophageal cancer	4.45e-05	7.44e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GAPDH—esophageal cancer	4.33e-05	7.24e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CRABP1—esophageal cancer	4.29e-05	7.18e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GNG7—esophageal cancer	4.08e-05	6.83e-05	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PIK3CA—esophageal cancer	3.91e-05	6.53e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ALDH2—esophageal cancer	3.83e-05	6.4e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTT1—esophageal cancer	3.64e-05	6.09e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	3.6e-05	6.02e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CREBBP—esophageal cancer	3.43e-05	5.74e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS1—esophageal cancer	3.41e-05	5.7e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ENO1—esophageal cancer	3.41e-05	5.7e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PSME2—esophageal cancer	3.36e-05	5.62e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PSME1—esophageal cancer	3.36e-05	5.62e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NOS3—esophageal cancer	3.07e-05	5.14e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	2.9e-05	4.85e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS2—esophageal cancer	2.81e-05	4.7e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.73e-05	4.56e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.49e-05	4.16e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.39e-05	3.99e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—EP300—esophageal cancer	2.34e-05	3.91e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PIK3CA—esophageal cancer	1.73e-05	2.89e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.6e-05	2.67e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NOS3—esophageal cancer	1.43e-05	2.39e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.31e-05	2.19e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—EP300—esophageal cancer	1.09e-05	1.82e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	8.04e-06	1.34e-05	CbGpPWpGaD
